Cargando…

Outcome after extended follow-up in a prospective study of operable breast cancer: key factors and a prognostic index

In 1990, 215 patients with operable breast cancer were entered into a prospective study of the prognostic significance of five biochemical markers and 15 other factors (pathological/chronological/patient). After a median follow-up of 6.6 years, there were 77 recurrences and 77 deaths (59 breast canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Hawkins, R A, Tesdale, A L, Prescott, R J, Forster, T, McIntyre, M A, Baker, P, Jack, W J L, Chetty, U, Dixon, J M, Killen, M E, Hulme, M J, Miller, W R
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2002
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364292/
https://www.ncbi.nlm.nih.gov/pubmed/12085248
http://dx.doi.org/10.1038/sj.bjc.6600335
_version_ 1782153918199889920
author Hawkins, R A
Tesdale, A L
Prescott, R J
Forster, T
McIntyre, M A
Baker, P
Jack, W J L
Chetty, U
Dixon, J M
Killen, M E
Hulme, M J
Miller, W R
author_facet Hawkins, R A
Tesdale, A L
Prescott, R J
Forster, T
McIntyre, M A
Baker, P
Jack, W J L
Chetty, U
Dixon, J M
Killen, M E
Hulme, M J
Miller, W R
author_sort Hawkins, R A
collection PubMed
description In 1990, 215 patients with operable breast cancer were entered into a prospective study of the prognostic significance of five biochemical markers and 15 other factors (pathological/chronological/patient). After a median follow-up of 6.6 years, there were 77 recurrences and 77 deaths (59 breast cancer-related). By univariate analysis, patient outcome related significantly to 13 factors. By multivariate analysis, the most important of nine independent factors were: number of nodes involved, steroid receptors (for oestrogen or progestogen), age, clinical or pathological tumour size and grade. Receptors and grade exerted their influence only in the first 3 years. Progestogen receptors (immunohistochemical) and oestrogen receptors (biochemical) were of similar prognostic significance. The two receptors were correlated (r=+0.50, P=0.001) and displaced each other from the analytical model but some evidence for the additivity of their prognostic values was seen when their levels were discordant. British Journal of Cancer (2002) 87, 8–14. doi:10.1038/sj.bjc.6600335 www.bjcancer.com © 2002 Cancer Research UK
format Text
id pubmed-2364292
institution National Center for Biotechnology Information
language English
publishDate 2002
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23642922009-09-10 Outcome after extended follow-up in a prospective study of operable breast cancer: key factors and a prognostic index Hawkins, R A Tesdale, A L Prescott, R J Forster, T McIntyre, M A Baker, P Jack, W J L Chetty, U Dixon, J M Killen, M E Hulme, M J Miller, W R Br J Cancer Clinical In 1990, 215 patients with operable breast cancer were entered into a prospective study of the prognostic significance of five biochemical markers and 15 other factors (pathological/chronological/patient). After a median follow-up of 6.6 years, there were 77 recurrences and 77 deaths (59 breast cancer-related). By univariate analysis, patient outcome related significantly to 13 factors. By multivariate analysis, the most important of nine independent factors were: number of nodes involved, steroid receptors (for oestrogen or progestogen), age, clinical or pathological tumour size and grade. Receptors and grade exerted their influence only in the first 3 years. Progestogen receptors (immunohistochemical) and oestrogen receptors (biochemical) were of similar prognostic significance. The two receptors were correlated (r=+0.50, P=0.001) and displaced each other from the analytical model but some evidence for the additivity of their prognostic values was seen when their levels were discordant. British Journal of Cancer (2002) 87, 8–14. doi:10.1038/sj.bjc.6600335 www.bjcancer.com © 2002 Cancer Research UK Nature Publishing Group 2002-07-01 2002-07-15 /pmc/articles/PMC2364292/ /pubmed/12085248 http://dx.doi.org/10.1038/sj.bjc.6600335 Text en Copyright © 2002 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Clinical
Hawkins, R A
Tesdale, A L
Prescott, R J
Forster, T
McIntyre, M A
Baker, P
Jack, W J L
Chetty, U
Dixon, J M
Killen, M E
Hulme, M J
Miller, W R
Outcome after extended follow-up in a prospective study of operable breast cancer: key factors and a prognostic index
title Outcome after extended follow-up in a prospective study of operable breast cancer: key factors and a prognostic index
title_full Outcome after extended follow-up in a prospective study of operable breast cancer: key factors and a prognostic index
title_fullStr Outcome after extended follow-up in a prospective study of operable breast cancer: key factors and a prognostic index
title_full_unstemmed Outcome after extended follow-up in a prospective study of operable breast cancer: key factors and a prognostic index
title_short Outcome after extended follow-up in a prospective study of operable breast cancer: key factors and a prognostic index
title_sort outcome after extended follow-up in a prospective study of operable breast cancer: key factors and a prognostic index
topic Clinical
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364292/
https://www.ncbi.nlm.nih.gov/pubmed/12085248
http://dx.doi.org/10.1038/sj.bjc.6600335
work_keys_str_mv AT hawkinsra outcomeafterextendedfollowupinaprospectivestudyofoperablebreastcancerkeyfactorsandaprognosticindex
AT tesdaleal outcomeafterextendedfollowupinaprospectivestudyofoperablebreastcancerkeyfactorsandaprognosticindex
AT prescottrj outcomeafterextendedfollowupinaprospectivestudyofoperablebreastcancerkeyfactorsandaprognosticindex
AT forstert outcomeafterextendedfollowupinaprospectivestudyofoperablebreastcancerkeyfactorsandaprognosticindex
AT mcintyrema outcomeafterextendedfollowupinaprospectivestudyofoperablebreastcancerkeyfactorsandaprognosticindex
AT bakerp outcomeafterextendedfollowupinaprospectivestudyofoperablebreastcancerkeyfactorsandaprognosticindex
AT jackwjl outcomeafterextendedfollowupinaprospectivestudyofoperablebreastcancerkeyfactorsandaprognosticindex
AT chettyu outcomeafterextendedfollowupinaprospectivestudyofoperablebreastcancerkeyfactorsandaprognosticindex
AT dixonjm outcomeafterextendedfollowupinaprospectivestudyofoperablebreastcancerkeyfactorsandaprognosticindex
AT killenme outcomeafterextendedfollowupinaprospectivestudyofoperablebreastcancerkeyfactorsandaprognosticindex
AT hulmemj outcomeafterextendedfollowupinaprospectivestudyofoperablebreastcancerkeyfactorsandaprognosticindex
AT millerwr outcomeafterextendedfollowupinaprospectivestudyofoperablebreastcancerkeyfactorsandaprognosticindex